Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 226 > >>
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(1E)-1-(9-bromo-3-phenanthryl)ethanone oxime 75% inhibition at 0.1 mM Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(2E)-2-[(2E)-2-[(diaminomethyl)hydrazono]-1-methylethylidene]hydrazinecarboximidamide i.e. MGBG, active site inhibitor Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(2E)-2-[4-[amino(imino)methyl]-2,3-dihydro-1H-inden-1-ylidene]hydrazinecarboximidamide i.e. CGP 48664A, stimulation in the range of 0.1-10 microM, inhibition at higher comcentration. Binds to the putrescine binding site and to the active site Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(2E)-2-[4-[amino(imino)methyl]-2,3-dihydro-1H-inden-1-ylidene]hydrazinecarboximidamide i.e. CGP48664A, SAM486A, active site inhibitor, in addition suppresses HIV-1 replication Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(2R,3R,4R,5R)-2-([[(2Z)-4-aminobut-2-en-1-yl](methyl)amino]methyl)-5-(6-amino-9H-purin-9-yl)-4-fluorotetrahydrofuran-3-ol - Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(2R,3R,4S,5R)-2-([[(2Z)-4-aminobut-2-en-1-yl](methyl)amino]methyl)-5-(6-amino-9H-purin-9-yl)-4-fluorotetrahydrofuran-3-ol - Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(2R,3S,4R,5R)-2-([[(2Z)-4-aminobut-2-en-1-yl](methyl)amino]methyl)-5-(6-amino-2-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diol - Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(5-deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium salt competitive with respect to S-adenosylmethionine; i.e. decarboxylated S-adenosylmethionine Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(5-deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium salt irreversible Go to the Ligand Summary Page
Show all pathways known for 4.1.1.50Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.50(5-deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium salt - Go to the Ligand Summary Page
Results 1 - 10 of 226 > >>
download as CSV
download all results as CSV